HIGH CALCIUM INSTANT FIBERICH MEAL COMBINATION PRODUCT POWDER

Indications

• Constipation
• Irritable bowel syndrome (IBS)
• Diverticular disease
• Hyperlipidemia
• Diabetes management
• Weight management

Dosage

Children: Refer to product-specific guidelines or consult a healthcare provider for appropriate dosing.

Adults: Refer to product-specific guidelines or consult a healthcare provider for appropriate dosing.

Mechanism of action

Dietary fibers work by adding bulk to the stool, which facilitates its passage through the intestines. They can also ferment in the colon, producing short-chain fatty acids that provide energy to colonic cells and have various health benefits. Soluble fibers can slow gastric emptying, which helps in regulating blood sugar levels and promoting satiety.

Pharmacodynamics

The pharmacodynamics of dietary fibers involve their ability to modulate gastrointestinal function and lipid metabolism. Soluble fibers can lower serum cholesterol levels by binding to bile acids, while insoluble fibers enhance gut motility and stool formation. Fiberich also supports the growth of beneficial gut microbiota, which can have a positive impact on overall health.

Pharmacokinetics

Dietary fibers are not absorbed in the gastrointestinal tract; rather, they pass through the digestive system largely intact. Soluble fibers can be fermented by gut bacteria, leading to the production of short-chain fatty acids. The efficacy of fiber supplements like Fiberich may vary based on the type of fiber included and individual digestive health.

Adverse effects

• Gastrointestinal discomfort
• Bloating
• Flatulence
• Diarrhea
• Constipation

Precautions

• Increase fiber intake gradually to prevent gastrointestinal distress.
• Ensure adequate fluid intake when consuming fiber supplements.
• Monitor for allergic reactions in individuals with known allergies to fiber sources.

Pregnancy

Fiber-rich diets are generally considered safe during pregnancy, but it is advisable to consult a healthcare provider for personalized recommendations.

Breast-feeding

Fiber is safe during breastfeeding and can help with postpartum gastrointestinal health.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Powder
• Capsules
• Tablets
• Granules

Indications

• Cancer treatment
• Severe infections requiring aggressive therapy
• Autoimmune disorders
• Certain chronic diseases

Dosage

Children: For paediatric patients, dosing must be determined on a case-by-case basis according to the specific medication and condition. Refer to the BNF for Children for detailed dosing information.

Adults: Dosage varies widely depending on the specific drug and condition being treated. Refer to the BNF for specific dosing guidelines.

Mechanism of action

High doses of drugs can enhance their pharmacological effects, potentially leading to increased efficacy. However, the specific mechanisms can vary widely depending on the drug in question. For instance, in chemotherapeutic agents, high doses may aim to saturate the target pathways or overcome resistance mechanisms in cancer cells.

Pharmacodynamics

Pharmacodynamics in high-dose therapy often involves the relationship between drug concentration and effect. At higher doses, the drug may produce a more pronounced response, but it also increases the likelihood of side effects. The therapeutic window may be narrower, necessitating careful monitoring of patient response and adverse effects.

Pharmacokinetics

The pharmacokinetics of drugs can be altered at high doses, affecting absorption, distribution, metabolism, and excretion. High doses may lead to saturation of metabolic pathways, prolonged half-lives, and accumulation of the drug in tissues. This can result in variable patient responses and necessitate dose adjustments based on therapeutic drug monitoring.

Interactions

• tamoxifen+high-dose: Unknown (increases concentration)
• corticosteroids+high-dose: Unknown (decreases concentration)
• erlotinib+high-dose: Unknown (increases risk of gastrointestinal perforation)
• live vaccines+high-dose: Unknown (increases risk of generalized infection (possibly life-threatening))
• atazanavir+high-dose: Unknown (increases exposure)

Indications

• Ethanol intoxication
• Detoxification in alcohol dependence
• Antiseptic and disinfectant
• Solvent in pharmaceutical preparations

Dosage

Children: Refer to BNF for Children for appropriate dosing information.

Adults: Refer to BNF for specific dosing information based on clinical indications.

Mechanism of action

Ethanol affects the brain’s neurons by altering their membranes, ion channels, enzymes, and receptors. It binds directly to GABA, glycine, NMDA, acetylcholine, and serotonin receptors, enhancing the inhibitory effects of GABA at GABAa receptors and blocking NMDA receptors for glutamate. This results in reduced excitatory neurotransmission, contributing to its sedative effects. Ethanol also acts as a dehydrating agent, disrupting osmotic balance across cell membranes, which enhances its anti-infective properties.

Pharmacodynamics

Ethanol produces cytotoxic effects through dehydration and precipitation of cellular components, leading to bacteriocidal and antifungal actions. It is metabolized primarily in the liver by alcohol dehydrogenase, with 90 to 98% of ethanol oxidized to acetaldehyde and further to acetic acid. The interaction of ethanol with various neurotransmitter receptors modulates neuronal signaling, which is responsible for its psychoactive effects. Chronic exposure leads to tolerance, characterized by adaptive changes in neurotransmitter systems.

Pharmacokinetics

Ethanol is rapidly absorbed from the gastrointestinal tract, with peak blood concentrations occurring approximately 30 to 90 minutes after consumption. It is distributed throughout body water, with a volume of distribution that varies based on fat and water content in the body. Ethanol is primarily metabolized in the liver, with a small fraction excreted unchanged in urine and breath. The elimination half-life can vary significantly based on individual metabolic rates and liver function.

Contra-indications

• Hypersensitivity to ethanol or any of its components
• Severe liver disease
• Active gastrointestinal bleeding
• Acute pancreatitis

Adverse effects

• Drowsiness
• Dizziness
• Nausea
• Vomiting
• Headache
• Impaired coordination
• Dependence and withdrawal symptoms with chronic use

Interactions

• Increased sedation with other CNS depressants (e.g., benzodiazepines, opioids)
• Inhibition of the metabolism of drugs metabolized by CYP2E1
• Potentially increased risk of gastrointestinal bleeding with nonsteroidal anti-inflammatory drugs (NSAIDs)
• May enhance the hypoglycemic effect of antidiabetic medications

Precautions

• Use with caution in patients with a history of alcohol use disorder
• Monitor for signs of liver function impairment
• Avoid use in pregnant women due to potential fetal harm
• Caution in patients with a history of seizure disorders

Pregnancy

Ethanol should be avoided during pregnancy due to the risk of fetal alcohol spectrum disorders.

Breast-feeding

Ethanol is excreted in breast milk; mothers should avoid alcohol consumption during breastfeeding.

Storage

Store in a cool, dry place away from light and tightly closed in its original container.

Formulations

• Oral solutions
• Topical antiseptic solutions
• Medicated syrups

Indications

• Nutritional support
• Energy provision
• Weight management
• Prevention of malnutrition
• Support of metabolic functions

Dosage

Children: Meal composition and frequency should be adjusted according to the child's age, growth requirements, and nutritional needs, following guidelines from pediatric nutrition resources.

Adults: Meals should be balanced and tailored to individual dietary needs, considering factors such as age, sex, activity level, and health status.

Mechanism of action

Meals provide essential nutrients that support various biochemical pathways in the body. Carbohydrates are broken down into glucose, which serves as the primary energy source for cells. Proteins are broken down into amino acids, which are used for tissue repair, enzyme production, and hormone synthesis. Fats are metabolized for energy and are vital for the absorption of fat-soluble vitamins.

Pharmacodynamics

The pharmacodynamics of meals involve the impact of food on bodily functions, including satiety, digestion, and nutrient absorption. The composition of a meal can influence blood glucose levels, insulin response, and overall energy metabolism. Meals that are high in fiber can enhance feelings of fullness and improve gastrointestinal health.

Pharmacokinetics

The pharmacokinetics of meals involve the absorption, distribution, metabolism, and excretion of nutrients. After consumption, food is digested in the gastrointestinal tract, where nutrients are absorbed into the bloodstream. Carbohydrates are metabolized into glucose, proteins into amino acids, and fats into fatty acids and glycerol, which are then utilized by the body or stored for future energy needs.

Pregnancy

Meals should be well-balanced and varied to ensure adequate nutrition for both the mother and developing fetus. Special attention should be given to food safety and hygiene.

Breast-feeding

A well-balanced diet is essential for lactating mothers to ensure adequate milk production and quality. Mothers should continue to eat a variety of foods to provide necessary nutrients to the infant.

Storage

Meals should be stored in clean, hygienic conditions. Perishable items should be refrigerated or frozen to prevent spoilage.

Mechanism of action

Ethanol affects the brain’s neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes. ... Ethanol is known to affect a large number of membrane proteins that participate in signaling pathways such as neurotransmitter receptors, enzymes, and ion channels, and there is extensive evidence that ethanol interacts with a variety of neurotransmitters. The major actions of ethanol involve enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABAa receptors and blockade of the N-methyl-D-aspartate (NMDA) subtype of glutamate, an excitatory amine acid (EAA) receptor. Animal studies indicate that the acute effects of ethanol result from competitive inhibition of glycine binding to NMDA receptor and disruption of glutamatergic neurotransmission by inhibiting the response of the NMDA receptor. Persistent glycine antagonism and attenuation of glutamatergic neurotransmission by chronic ethanol exposure results in tolerance to ethanol by enhancing EAA neurotransmission and NMDA receptor upregulation. The latter appears to involve selective increases in NMDA R2B subunit concentrations and other molecular changes in specific brain loci. The abrupt withdrawal of ethanol thus produces a hyperexcitable state that leads to the ethanol withdrawal syndrome and excitotoxic neuronal death. GABA-mediated inhibition, which normally acts to limit excitation, is eliminated during ethanol withdrawal syndrome and further intensifies this excitation. In addition, NMDA receptors function to inhibit the release of dopamine in the nucleus accumbens and mesolimbic structures, which modulate the reinforcing action of addictive xenobiotics such as ethanol. By inhibiting NMDA receptor activity, ethanol could increase dopamine release from the nucleus accumbens and ventral tegmental area and could thus create dependence. Chronic ethanol administration also results in tolerance, dependence, and an ethanol withdrawal syndrome, mediated, in part, by desensitization and or downregulation of GABAa receptors. The development of alcoholic ketoacidosis (AKA) requires that a combination of physical and physiologic events occur. The normal response to starvation and depletion of hepatic glycogen stores is for amino acids to be converted to pyruvate. Pyruvate can serve as a substrate for gluconeogenesis, be converted to acetyl-CoA, which can enter the Krebs cycle or can be utilized in various biosynthetic pathways (eg, fatty acid, ketone bodies, cholesterol, and acetylcholine) ... Ethanol metabolism generates NADH, resulting in an excess of reducing potential. This high redox state favors the conversion of pyruvate to lactate, diverting pyruvate from being a substrate for gluconeogenesis. To compensate for the lack of normal metabolic substrates, the body mobilizes fat from adipose tissue and increased fatty acid metabolism as an alternative source of energy. This response is mediated by a decrease in insulin and an increased secretion of glucagon, catecholamines, growth hormone, and cortisol. Fatty acid metabolism results in the formation of acetyl-CoA and it combines with the excess acetate that is generated from ethanol metabolism to form acetoacetate. Most of the acetoacetate is reduced to beta-hydroxybutyrate due to the excess reducing potential or high redox state of the cell. Volume depletion interferes with the renal elimination of acetoacetate and beta-hydroxybutyrate, and contributes to the acidosis. An elevated lactate concentration may result from shunting from pyruvate or

Pharmacodynamics

Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol also binds to GABA, glycine, NMDA receptors and modulates their effects. Ethanol is also metabolised by the hepatic enzyme alcohol dehydrogenase.